This is a preview of subscription content, log in via an institution to check access.
References
Cheng, Y.H., Qi, J., Xiong, D.S., Liu, J.W., Qi, S.L., Pan, B., Yang, C.Z., Zhu, H.F., 2006. Reversal of multidrug resistance in drug-resistant human breast cancer cell line MCF-7/ADR by calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine. Acta Acad. Med. Sin., 28(2):164–168 (in Chinese).
Du, H.P., Shen, J.K., Yang, M., Wang, Y.Q., Yuan, X.Q., Ma, Q.L., Jin, J., 2010. 4-Chlorobenzoyl berbamine induces apoptosis and G2/M cell cycle arrest through the PI3K/Akt and NF-kappaB signal pathway in lymphoma cells. Oncol. Rep., 23(3):709–716.
Duan, H., Luan, J., Liu, Q., Yagasaki, K., Zhang, G., 2010. Suppression of human lung cancer cell growth and migration by berbamine. Cytotechnology, 62(4):341–348. [doi:10.1007/s10616-009-9240-x]
Liang, Y., Xu, R.Z., Zhang, L., Zhao, X.Y., 2009a. Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells. Acta Pharmacol. Sin., 30(12):1659–1665. [doi:10.1038/aps.2009.167]
Liang, Y., Zhao, X.Y., Wei, Y.L., Xu, R.Z., 2009b. Berbamine induces apoptosis of multiple myeloma RPMI 8226 cells by activating GADD45/JNK pathway. J. Zhejiang Univ. (Med. Sci.), 38(5):439–444 (in Chinese).
Liang, Y., Qiu, X., Xu, R.Z., Zhao, X.Y., 2011. Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 12(7):568–574. [doi:10.1631/jzus.B1000230]
Liu, R., Zhang, Y., Chen, Y., Qi, J., Ren, S.M., Xushi, M.Y., Yang, C.Z., Zhu, H., Xiong, D.S., 2010. A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells. J. Pharm. Sci., 99(7):3266–3275. [doi:10.1002/jps.22082]
Wang, G.Y., Zhang, J.W., Lu, Q.H., Xu, R.Z., Dong, Q.H., 2007. Berbamine induces apoptosis in human hepatoma cell line SMMC7721 by loss in mitochondrial transmembrane potential and caspase activation. J. Zhejiang Univ.-Sci. B, 8(4):248–555. [doi:10.1631/jzus.2007.B0248]
Wang, G.Y., Lv, Q.H., Dong, Q., Xu, R.Z., Dong, Q.H., 2009. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice. J. Asian Nat. Prod. Res., 11(3):219–228. [doi:10.1080/10286020802675076]
Wang, S., Liu, Q., Zhang, Y., Liu, K., Yu, P.F., Liu, K., Luan, J.L., Duan, H.Y., Lu, Z.Q., Wang, F.F., et al., 2009. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol. Cancer, 8(1):81. [doi:10.1186/1476-4598-8-81]
References
Du, H.P., Shen, J.K., Yang, M., Wang, Y.Q., Yuan, X.Q., Ma, Q.L., Jin, J., 2010. 4-Chlorobenzoyl berbamine induces apoptosis and G2/M cell cycle arrest through the PI3K/Akt and NF-kappaB signal pathway in lymphoma cells. Oncol. Rep., 23(3): 709–716.
Kapoor, S., 2012. Emerging role of berbamine as an anti-cancer agent in systemic malignancies besides chronic myeloid leukemia. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 13(9):761–762. [doi:10.1631/jzus.B1200110]
Liang, Y., Qiu, X., Xu, R.Z., Zhao, X.Y., 2011. Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 12(7):568–574. [doi:10.1631/jzus.B1000230]
Liu, R., Zhang, Y., Chen, Y., Qi, J., Ren, S.M., Xushi, M.Y., Yang, C.Z., Zhu, H., Xiong, D.S., 2010. A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells. J. Pharm. Sci., 99(7):3266–3275. [doi:10.1002/jps.22082]
Wang, G.Y., Lv, Q.H., Dong, Q., Xu, R.Z., Dong, Q.H., 2009. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice. J. Asian Nat. Prod. Res., 11(3):219–228. [doi:10.1080/10286020802675076]
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kapoor, S., Liang, Y., Qiu, X. et al. Emerging role of berbamine as an anti-cancer agent in systemic malignancies besides chronic myeloid leukemia. J. Zhejiang Univ. Sci. B 13, 761–762 (2012). https://doi.org/10.1631/jzus.B1200110
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B1200110